Extracorporeal Circulation
Organ Damage
John W. Hammon,
Jr./ L. Henry Edmunds, Jr.
 |
INTRODUCTION
|
Cardiopulmonary
bypass preempts normal reflex and chemoreceptor control of the
circulation, initiates coagulation, activates blood cells, releases
circulating cell-signaling proteins, generates vasoactive and
cytotoxic substances, and produces a variety of microemboli. Venous
pressure is elevated, plasma colloid osmotic pressure is reduced,
flow is nonpulsatile, and temperature is manipulated. Tissues and
organs suffer from regional malperfusion of blood flow that is
independent of physiologic controls, and is caused by bombardment of
microemboli, increased interstitial water, and perfusion with an
enzymatic stew of cytotoxic substances. Reversible and irreversible
cell injury occur, but damage is diffusely distributed throughout the
entire body as individual cells or small groups of cells are
affected. Ischemia-reperfusion injury augments damage to the heart
and on occasion to other organs. Amazingly, the body is able to
withstand and for the most part repair this physiologic chaos and
massive assault of angry blood. This section summarizes the
reversible and permanent organ damage produced by cardiopulmonary
bypass (CPB) and complements the preceding three sections of this
chapter and the chapter on ischemia and reperfusion (see Ch. 3).
 |
MECHANISMS
|
Cardiac
output during CPB is carefully monitored and synchronized with
temperature and hemoglobin concentration to ensure that the entire
body is adequately supplied with oxygen (see earlier section on
extracorporeal perfusion systems). Excessive hemodilution reduces
oxygen delivery,700
and hemoglobin concentrations below 8g/L cause organ dysfunction at
temperatures above 30°C.701
However, regional hypoperfusion is not monitored702;
is independent of reflex and chemoreceptor controls; and is
influenced by the inflammatory response, which produces circulating
vasoactive substances,703,704
defined as substances that cause vascular smooth muscle cells and/or
endothelial cells to contract or relax (see earlier section on
inflammatory response). Regional perfusion is also influenced by
acid-base relationships during cooling and may affect postoperative
organ function.705,706
Alpha-stat management (pH increases during cooling) decreases
cerebral perfusion during hypothermia; pH stat (pH 7.40 is maintained
by adding CO2) improves organ perfusion but may increase
embolic injury.707
Temperature differences within the body and within organs produce
regional temperature-perfusion mismatch,708
which can precipitate regional hypoperfusion and acidosis due to
inadequate oxygen delivery. There is no method to monitor regional
perfusion during cardiopulmonary bypass, and even direct temperature
surveillance of vital organs may fail to detect temperature
differences within the organ.
The inflammatory response produces the terminal complement attack
complex, anaphylatoxins, cytotoxic proteases,709
collagenases, gelatinases, metalloproteinases,710
reactive oxidants, free radicals, lipid peroxide, endotoxin,
inflammatory cytokines, and activated neutrophils and monocytes that
can and do destroy organ and tissue cells (see section 11C). These
agents directly access the specialized cells of every organ by
passing between endothelial cell junctions to reach the interstitial
compartment. Reduced plasma colloid osmotic pressure, elevated venous
pressure, and widened endothelial cell junctions711
increase the volume of the interstitial space during CPB in
proportion to the duration of bypass, magnitude of the dissection,
transfusions, and other factors. In prolonged complicated perfusions
the interstitial compartment may increase 18% to 33%,712
but intracellular water does not increase during CPB.
Microemboli are defined as particles less than 500 microns in
diameter. They enter the circulation during CPB from a variety
of sources.713
Table
11-5 summarizes sources of gas, foreign, and blood-generated
microemboli, which are more fully discussed in section 11A. Air entry
into the perfusion circuit produces the most dangerous gas emboli
because nitrogen is poorly soluble in blood and is not a metabolite.
Carbon dioxide is rapidly soluble in blood and is sometimes used to
flood the surgical field to displace air.714
Foreign emboli, largely generated in the surgical wound, reach the
circulation from the surgical field via the cardiotomy reservoir. The
cardiotomy reservoir is the primary source of foreign emboli and the
major source of blood-generated emboli, particularly fat emboli.715
Extensive activation and physical damage to blood elements produce a
wide variety of emboli, which tend to increase with the duration
of perfusion.716,717
 |
STRATEGIES
FOR REDUCING MICROEMBOLI |
Although
discussed in earlier sections, the principal methods for reducing
circulating microemboli deserve emphasis and include the following:
adequate anticoagulation; membrane oxygenator; washing blood
aspirated from the surgical wound718;
filter in the cardiotomy reservoir; secure purse-string sutures
around cannulas; strict control of all air entry sites within the
perfusion circuit; removal of residual air from the heart and great
vessels; avoidance of atherosclerotic emboli; and selective
filtration of cerebral vessels.719,720
Many intraoperative strategies are available to reduce cerebral
atherosclerotic embolization. These include routine epicardial
echocardiography of the ascending aorta to detect both anterior
and posterior atherosclerotic plaques and to find sites free of
atherosclerosis for placing the aortic cannula.721
Recently, special catheters with or without baffles or screens have
been developed to reduce the number of atherosclerotic emboli
that reach the cerebral circulation.719–724
In patients with moderate or severe ascending aortic atherosclerosis
a single application of the aortic clamp as opposed to partial or
multiple applications is strongly recommended and has been shown to
reduce postoperative neuronal and neurocognitive deficits in a
large clinical series.725
Retrograde cardioplegia is preferred over antegrade cardioplegia in
these patients to avoid a sandblasting effect of the cardioplegic
solution.726
No aortic clamp may be safe or even possible in some patients with
severe atherosclerosis or porcelain aorta. If intracardiac surgery is
required in these patients, deep hypothermia may be used with or
without graft replacement of the ascending aorta. If only
revascularization is needed, pedicled single or sequential arterial
grafts,727
T or Y grafts from a pedicled mammary artery,728
or vein grafts anastomosed to arch vessels can be used.
In-depth or screen filters (see section 11A) are essential for
cardiotomy reservoirs and are usually used in arterial lines.
The efficacy of arterial line filters is controversial since
screen filters with a pore size less than 25 to 40 microns cannot
be used because of flow resistance across the filter. Moreover,
air and fat emboli can pass through filters and air and
atherosclerotic emboli may enter the circulation downstream to the
filter.
 |
CARDIAC
INJURY |
It is
difficult to separate postoperative cardiac dysfunction from injury
due to CPB, ischemia/reperfusion, direct surgical trauma, the disease
being treated, and maladjustment of preload and afterload to
myocardial contractile function. The heart, like all organs and
tissues, is subject to microemboli, protease and chemical cytotoxins,
activated neutrophils and monocytes, and regional hypoperfusion
during CPB before and after cardioplegia or fibrillatory arrest. Some
degree of myocardial "stunning" during the period coronary blood flow
is interrupted is inevitable,729
as is some degree of reperfusion injury after ischemia. Both
myocardial edema and distention of the flaccid cardioplegic
heart during aortic cross-clamping730
reduce myocardial contractility. Lastly, if myocardial contractility
is weak, excessive preload or high afterload during weaning from CPB
increases ventricular end-diastolic volume, myocardial wall stress,
and oxygen consumption. Thus postoperative performance of the heart
depends upon many variables and not just the injuries produced by
CPB.
 |
NEUROLOGIC
INJURY |
Because
the brain controls all body activity, even small injuries to it may
produce detectable, functional losses that are not detectable or
important in other organs. Regional hypoperfusion, edema,
microemboli, and circulating cytotoxins may cause subtle losses in
cognitive function, behavioral patterns, and physiologic and physical
function that can pass unnoticed, be accepted and dismissed, or
profoundly compromise the patient's quality of life. Thus the brain
is the most sensitive organ exposed to damage by CPB and also the
organ that it is most important to protect.
Assessment
Routine assessment of neurologic injury due to cardiopulmonary
bypass is not done for most patients because of the priority of
the cardiac lesion and because of costs in time and money. General
neurologic examinations by untrained individuals or by members of the
surgical team are not adequate to rule out subtle neurologic
injuries, and this is the principal reason that the incidence of
post–CPB, nonstroke, neurologic injury varies widely in the surgical
literature.731–733
For studies designed to assess or reduce neurologic injury caused
by CPB, nonroutine preoperative and postoperative tests are
required. These special tests include a complete neurologic
examination by a trained neurologist. To improve accuracy, a
single neurologist should conduct all serial examinations. A
standardized protocol of examination should be followed, with
uniform reporting of results. The basic, structured examination
includes a mental state examination; cranial nerve, motor, sensory,
and cerebellar examinations; and examination of gait, station,
deep tendon, and primitive reflexes.
The most obvious neuropsychologic abnormalities are coma, delirium,
and confusion, but transitory episodes of delirium and confusion
are often dismissed as due to anesthesia or medications. More
subtle losses are determined by comparison of preoperative and
postoperative performances using a standard battery of
neuropsychologic tests prepared by a group of neuropsychologists.734
A 20% decline in two or more of these tests suggests a
neuropsychologic deficit that should be followed until resolved or
not resolved.735
Computed axial tomograms (CAT) or magnetic resonance imaging (MRI)
scans are essential for the definitive diagnosis of stroke, delirium,
or coma. Preoperative imaging is usually not necessary when new
techniques such as diffusion-weighted MRI imaging, MRI spectroscopy,
or MRI angiography are used to assess possible new lesions after
operation.736–738
Biochemical markers of neurologic injury after cardiac surgery are
relatively nonspecific and inconclusive. Neuron-specific enolase
(NSE) is an intracellular enzyme found in neurons, normal
neuroendocrine cells, platelets, and erythrocytes.739
S-100 is an acidic calcium-binding protein found in the brain.740,741
The beta dimer resides in glial and Schwann cells. Both S-100
and NSE increase in spinal fluid with neuronal death740,742
and may correlate with neurologic injury after CPB,742
but the tests are contaminated by red cell and platelet
destruction and are often elevated following prolonged CPB in
patients without otherwise detectable neurologic injury.743
Populations at Risk
Advancing age increases the risk of stroke or cognitive impairment
in the general population, and surgery, regardless of type,
increases the risk still higher.744
A European study compared 321 elderly patients without surgery to
1218 patients who had noncardiac surgery and found a 26% incidence of
cognitive dysfunction 1 week after operation and a 10% incidence at 3
months.745
Between 1974 and 1990 the number of patients undergoing cardiac
surgery over age 60 and over age 70 increased 2-fold and 7-fold,
respectively.746
Figure
11-21 illustrates the relationship between age and cognitive
dysfunction after CABG and demonstrates a steep increase after
the age of 60. Genetic factors also influence the incidence of
cognitive dysfunction following cardiac surgery.747
The incidence of cognitive dysfunction at 1 week following cardiac
surgery is approximately double that of noncardiac surgery.
 View larger version
(16K): [in
this window] [in a new window] |
FIGURE 11-21 Effect of age by
decade on neuropsychologic outcome after CABG. Abnormal
neuropsychologic outcomes at 1 week and 1 month postoperative are
more common with advancing age. Percentages of patients with
deficits on two or more tests are shown (N = 374). (Reproduced
with permission from Hammon JW, Stump DA, Kon ND, et al: Risk
factors and solutions for the development of neurobehavioral changes
after coronary artery bypass grafting. Ann Thorac Surg 1998:
63:1613.)
| |
As
the age of cardiac surgical patients increases, the number with
multiple risk factors for neurologic injury also increases. Risk
factors for adverse cerebral outcomes are listed in Table
11-6. 748
These factors are divided into stroke with a permanent fixed
neurologic deficit (type 1) and coma or delirium (type 2).
Hypertension and diabetes occur in approximately 55% and 25% of
cardiac surgical patients, respectively.749
Fifteen percent have carotid stenosis of 50% or greater, and up to
13% have had a transient ischemic attack or prior stroke.749
The total number of atherosclerotic stenoses in the brachiocephalic
vessels adds to the risk of stroke or cognitive dysfunction,750
as does the severity of atherosclerosis in the ascending aorta as
detected by epiaortic ultrasound scanning.751
Palpable ascending aortic atherosclerotic plaques markedly increase
the risk of right carotid arterial emboli as detected by Doppler
ultrasound.752
The incidence of severe aortic atherosclerosis is 1% in cardiac
surgical patients less than 50 years old and is 10% in those
aged 75 to 80.753
Mechanisms of
Injury
The two major causes of organ dysfunction and injury during CPB
are microemboli and hypoperfusion, which are to some extent mutually
exclusive. Microemboli are distributed in proportion to blood flow754;
thus reduced cerebral blood flow reduces microembolic injury but
increases the risk of hypoperfusion.754
During CPB both alpha-stat acid-base management and phenylepherine
reduce cerebral injury in adults, probably by causing cerebral
vessel vasoconstriction and reducing the number of microemboli.755,756
Air,757
atherosclerotic debris,758
and fat are the major types of microemboli causing brain injury in
clinical practice, and all cause neuronal necrosis by blocking small
cerebral vessels.707,759
Massive air embolism causes a large ischemic injury, but gaseous
cerebral microemboli may directly damage endothelium in addition
to blocking blood flow.759
The recent identification of unique small capillary arteriolar
dilatations (SCADs) in the brain associated with fat emboli (Fig.
11-22)760
raises the possibility that these emboli not only block small vessels
but also release cytotoxic free radicals, which may significantly
increase the damage to lipid-rich neurons.
 View larger version
(100K): [in
this window] [in a new window] |
FIGURE 11-22 Small capillary and
arterial dilatations (SCADs) in cerebral vessels in a patient who
expired 48 hours after CABG using cardiopulmonary bypass. (Alkaline
phosphatase-stained celloidin section, 100 µm thick: X100.)
| |
Anemia
and elevated cerebral temperature increase cerebral blood flow but
may cause inadequate oxygen delivery to the brain761;
however, these conditions are easily avoided during clinical
cardiac surgery. Although some investigators speculate that
normothermic and/or hyperthermic CPB cause cerebral hypoperfusion,762
experimental studies indicate that cerebral blood flow increases
with temperature.754
Brain injuries associated with this practice are more likely due to
increased cerebral microemboli, which produce larger lesions at
higher cerebral temperatures.754
Reduced brain temperature is protective against neural cell
necrosis and remains an important neuroprotective strategy.
Additional Neuroprotective Strategies
Primary strategies for avoiding air, atherosclerotic particulates,
and blood-generated microembolism are presented above and in
section 11A. Recommended conditions for protecting the brain
during CPB include mild hypothermia (32°C-34°C) and hematocrit
above 25%.763
Temporary increases in cerebral venous pressure caused by superior
vena cava obstruction and excessive rewarming above blood
temperatures of 37°C should be avoided.764–766
Either jugular venous bulb oxygen saturation or near-infrared
cerebral oximetry are recommended for monitoring cerebral perfusion
in patients who may be at high risk for cerebral injury.767
Barbiturates reduce cerebral metabolism by decreasing spontaneous
synaptic activity768
and provide a definite neuroprotective effect during clinical cardiac
surgery using CPB.769
Unfortunately, these agents delay emergence from anesthesia and
prolong intensive care unit stays. NMDA (N-methyl-D asparate)
antagonists, which are effective in animals, provide mild protection
compared to control patients, but have a high incidence of neurologic
side effects.770
A small study demonstrated a neuroprotective effect of lidocaine.771
Currently no agent is recommended for protection of the central
nervous system during CPB.
Off-pump myocardial revascularization theoretically avoids many of
the causes of cerebral injury due to CPB, but, as noted above, many
causes of neuronal injury are independent of CPB and related to
atherosclerosis and air entry sites into the circulation.
Measurements of carotid emboli by Doppler ultrasound indicate
fewer emboli and improved neurocognitive outcomes in patients
who have off-pump surgery as compared to those with on-pump
revascularization772,773;
however, a definitive, randomized trial, which is necessary to
neutralize patient-related causes of injury, has not been done.
Prognosis
Neuropsychologic deficits that are present after 3 months are
almost always permanent.774
Assessments after that time are confounded by development of new
deficits, particularly in aged patients.775
 |
LUNG INJURY
|
Patient
factors and the separate effects of operation and CPB combine to
compromise lung function early after operation. Chronic smoking and
emphysema are the most common patient factors, but muscular weakness,
chronic bronchitis, occult pneumonia, preoperative pulmonary edema,
and unrelated respiratory disease are other contributors to
postoperative pulmonary dysfunction. Incisional pain, lack of
movement, shallow respiratory sighs, increased work of breathing,
reduced pulmonary compliance, weak cough, increased pulmonary
arterial-venous shunting, and interstitial edema, to some degree, are
consequences of anesthesia and any operation. CPB significantly adds
to this injury.
During CPB the lungs are supplied by the bronchial arteries and
pulmonary arterial blood flow may be absent or minimal. Whether or
not alveolar cells suffer an ischemic/reperfusion injury is unclear,
but the lungs are subject to many insults that combine to increase
pulmonary capillary permeability and interstitial lung water.
Hemodilution, reduced plasma oncotic pressure, and temporary
elevation of left atrial or pulmonary venous pressure during CPB or
during weaning from CPB increase extravascular lung water.776,777
Microemboli778
and circulating cellular, vasoactive, and cytotoxic mediators of the
inflammatory response779–783
reach the lung via bronchial arteries during CPB and with resumption
of the pulmonary circulation during weaning. These agents increase
pulmonary capillary permeability, perivascular edema, and bronchial
secretions, and perhaps cause observed changes in alveolar
surfactant.784
The combination of increased interstitial lung water and bronchial
secretions, altered surfactant, patient factors, and the consequences
of operation reduces pulmonary compliance and functional
residual capacity and increases the work of breathing.785
All of these changes combine to enhance regional atelectasis,
increase susceptibility to infection, and increase the physiologic
arterial-venous shunt, which reduces systemic arterial PaO2.
Postoperative respiratory care is based upon restoring normal
pulmonary capillary permeability and interstitial lung volume;
preventing atelectasis; reinflating atelectatic segments; maintaining
normal arterial blood gases; and preventing infection and
facilitating removal of bronchial mucus. Improved postoperative
respiratory care, an understanding of the mechanisms of lung injury
during CPB, and efforts to prevent or control the causes of injury786,787
have markedly reduced the incidence of pulmonary complications
in recent years.785
(See Ch. 15 for a more detailed discussion of postoperative
care.)
Acute respiratory distress syndrome (ARDS) is a rare complication
of lung injury during cardiopulmonary bypass and is usually
caused by intrabronchial bleeding from traumatic injury by the
endotracheal tube or pulmonary artery catheter788
or to extravasation of blood into alveoli from acute increases in
pulmonary venous pressure or severe pulmonary capillary toxic
injury.
 |
RENAL INJURY
|
As with
other organs, the preoperative health of the kidneys is a major
factor in the ability of that organ to withstand the microembolic,
cellular,789
and regional malperfusion injuries caused by CPB. Risk factors for
postoperative renal dysfunction include age over 70 years, diabetes
mellitus, previous cardiac surgery, congestive heart failure, and a
complex, prolonged operation.790
The incidence of acute renal failure requiring dialysis after CPB is
remarkably low, averaging 1%; however, the incidence increases to 5%
with complex operations.791
Some degree of renal injury is inevitable during CPB792
and postperfusion proteinuria occurs in all patients.793
Increased expression of neutrophil CD 11b receptors and elevated
neutrophil count are significantly related to postoperative acute
renal failure, defined as a 150% increase in plasma creatinine
over baseline.789
Renal blood and plasma flow, creatinine clearance, free water
clearance, and urine volume decrease without hemodilution.794
Hemodilution attenuates most of these functional changes and
also reduces the risk of hemoglobin precipitation in renal tubules
if plasma-binding proteins become saturated with free hemoglobin
during extracorporeal perfusion. Hemoglobin is toxic to renal
tubules and precipitation can block both blood and urine flow
to the tubules.795
Hemodilution dilutes plasma hemoglobin; improves flow to the outer
renal cortex; improves total renal blood flow; increases creatinine,
electrolyte, and water clearance; and increases glomerular filtration
and urine volume.794
Perioperative periods of low cardiac output and/or hypotension
added to the microembolic, cellular, and cytotoxic injuries of
CPB and to any preoperative renal disease are the major cause of
postoperative renal failure.789,796
Low cardiac output reduces renal perfusion pressure and causes
angiotensin II production and renin release, which further decrease
renal blood flow. Kidneys, already compromised by preoperative
disease and the CPB injury, are particularly sensitive to ischemic
injury secondary to low cardiac output and hypotension. Thus
perioperative management includes efforts to maximize cardiac output
using dopamine or dobutamine if necessary,797
avoiding renal arterial vasoconstrictive drugs, providing adequate
crystalloid infusions to maintain urine volume, and alkalinizing
urine to minimize precipitation of tubular hemoglobin if excessive
hemolysis has occurred. Preliminary studies with a natruetic peptide
found in human urine, urodilantin, indicate the possibility of
attenuating postoperative oliguria.798
If perioperative low cardiac output and hypotension do not occur,796
the normal kidney has sufficient functional reserve to provide
adequate renal function during and after operation. The appearance
of oliguric renal failure is ominous and usually requires dialysis,
which is generally permanent if required for more than 2 weeks.799
Oliguric renal failure markedly increases morbidity and mortality
by approximately 8-fold.800
 |
INJURY TO THE
LIVER AND GASTROINTESTINAL ORGANS |
Although
subjected to microemboli, cytotoxins, and regional malperfusion
during CPB, the enormous functional reserve and reparative processes
of the normal liver nearly always overcome the injury without
consequences. Often liver enzymes are mildly elevated,801
and 10% to 20% of patients are mildly jaundiced.802
Extensive red cell hemolysis increases the likelihood of mild
jaundice. Persistent and rising jaundice 2 or more days after
CPB may precede development of liver failure and is associated
with increased morbidity and mortality.803
Catastrophic liver failure, however, occurs in patients with
overwhelming sepsis, oliguric renal failure, anesthetic or drug
toxicity, or after a prolonged period of low cardiac output or an
episode of hemorrhagic shock and multiple blood transfusions and is
uniformly fatal.804
The liver usually is involved in patients who develop multiorgan
failure.
 |
PANCREATIC
INJURY |
Less then
1% of patients develop clinical pancreatitis after CPB, but
approximately 30% develop a transitory, asymptomatic increase in
plasma amylase and/or lipase.805–807
Autopsy studies of the pancreas soon after CPB indicate occasional
evidence of histologic pancreatitis.808
A history of recurrent pancreatitis, perioperative circulatory shock
or hypotension, excessively prolonged CPB, and continuous, high doses
of inotropic agents are risk factors for developing postoperative
pancreatitis.809
Experimentally and clinically, high doses of calcium increase
intracellular trypsinogen activation and histologic evidence of
pancreatitis.810–812
Fulminant pancreatits is very rare, but is often fatal.813
 |
STOMACH AND
GUT INJURY |
CPB at
adequate flow rates does not decrease splanchnic blood flow.814
Risk factors for gastrointestinal complications include advanced age,
emergency surgery, prolonged CPB, postoperative low cardiac output or
shock, prolonged vasopressor therapy, and elevated preoperative
systemic venous pressure.815
CPB decreases gastric pH, which declines further after operation.816
Prior to the advent of H2 blockers and regular use of antacids,
duodenal and/or gastric erosion, ulcer, and bleeding were frequent
complications following clinical cardiac surgery817
and were associated with mortality that approached 33% to 50%.818
These complications are now uncommon.
Several days to 1 week after operation very elderly patients
rarely may develop mesenteric vasculitis or severe mesenteric
vasoconstriction in response to vasopressors that proceeds to
small bowel ischemia and/or infarction. New onset abdominal
pain with a silent, rigid abdomen and abrupt rise in white count
may be the only signs of this catastrophic complication, which
is frequently fatal. If suspected before infarction, infusion
of papaverine or alternative vasodilators directly into the
mesenteric arteries may prevent or limit subsequent infarction.819,820
The role of CPB in the etiology of this complication is not
known.
 |
REFERENCES
|
Levy JH, Hug CC: Use of cardiopulmonary bypass in studies
of the circulation. Br J Anaesth 1988; 60:35S.[Medline]
Carson JL, Poses RM, Spence RK, et al: Severity of
anaemia and operative mortality and morbidity. Lancet 1988; 1:727.[Medline]
Kolkka R, Hilberman M: Neurologic dysfunction following
cardiac operation with low-flow, low-pressure cardiopulmonary bypass. J
Thorac Cardiovasc Surg 1980; 79:432.[Abstract]
Downing SW, Edmunds LH Jr: Release of vasoactive
substances during cardiopulmonary bypass. Ann Thorac Surg 1992;
54:1236.[Abstract]
Robicsek F, Masters TN, Niesluchowski W, et al: Vasomotor
activity during cardiopulmonary bypass, in Utley JR (ed): Pathophysiology
and Techniques of Cardiopulmonary Bypass, vol II. Baltimore, Williams
& Wilkins, 1983; p
1.
Murkin JM, Martzke JS, Buchan AM, et al: A randomized
study of the influence of perfusion technique and pH management strategy in
316 patients undergoing coronary artery bypass surgery, II: neurologic and
cognitive outcomes. J Thorac Cardiovasc Surg 1995; 110: 349.[Abstract/Free Full Text]
Patel RL, Turtle MR, Chambers DJ, et al: Alpha-stat
acid-base regulation during cardiopulmonary bypass improves neuropsychologic
outcome in patients undergoing coronary artery bypass grafting. J Thorac
Cardiovasc Surg 1996; 111:1267.[Abstract/Free Full Text]
Stump DA, Brown WR, Moody DM, et al: Microemboli and
neurologic dysfunction after cardiovascular surgery. Semin Cardiothorac
Vascular Anesth 1999; 3:47.
Stone JG, Young WL, Smith CR, et al: Do standard
monitoring sites reflect true brain temperature when profound hypothermia is
rapidly induced and reversed? Anesthesiology 1995; 82:344.[Medline]
Faymonville ME, Pincemail J, Duchateau MD, et al:
Myeloperoxidase and elastase as markers of leukocyte activation during
cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg 1991;
102:309.[Abstract]
Joffs C, Gunasinghe HR, Multani MM, et al:
Cardiopulmonary bypass induces the synthesis and release of matrix
metalloproteinases. Ann Thorac Surg 2001; 71:1518.[Abstract/Free Full Text]
Smith EEJ, Naftel DC, Blackstone EH, Kirklin JW:
Microvascular permeability after cardiopulmonary bypass. J Thorac
Cardiovasc Surg 1987; 94:225.[Abstract]
Pacifico AD, Digerness S, Kirklin JW: Acute alterations
of body composition after open intracardiac operations. Circulation
1970;41:331.[Medline]
Edmunds LH Jr, Williams W: Microemboli and the use of
filters during cardiopulmonary bypass, in Utley JR (ed): Pathophysiology
and Techniques of Cardiopulmonary Bypass, vol II. Baltimore, Williams
& Wilkins, 1983; p. 101.
Webb WR, Harrison LH, Helmcke FR, et al: Carbon dioxide
field flooding minimizes residual intracardiac air after open-heart
operations. Ann Thorac Surg 1997; 64:1489.[Abstract/Free Full Text]
Brooker RF, Brown WR, Moody DM, et al: Cardiotomy
suction: a major source of brain lipid emboli during cardiopulmonary bypass.
Ann Thorac Surg 1998; 65:1651.[Abstract/Free Full Text]
Lee WH Jr, Krumhaar D, Fonkalsrud EW, et al: Denaturation
of plasma proteins as a cause of morbidity and death after intracardiac
operations. Surgery 1961; 50:1025.
Slogoff S, Girgis KZ, Keats AS: Etiologic factors in
neuropsychiatric complications associated with cardiopulmonary bypass.
Anesth Analg 1982; 61:903.[Abstract]
Kincaid EH, Jones TJ, Stump DA, et al: Processing
scavenged blood with a cell saver reduces cerebral lipid microembolization.
Ann Thorac Surg 2000; 70:1296.[Abstract/Free Full Text]
Reichenspurner H, Navia JA, Benny G et al: Particulate
embolic capture by an intra-aortic filter device during cardiac surgery. J
Thorac Cardiovasc Surg 2000;
119:233.[Abstract/Free Full Text]
Cook DJ, Zehr KJ, Orszulak TA, Slater JM: Profound
reduction in brain embolization using an endoaortic baffle during bypass in
swine. Ann Thorac Surg 2002; 73: 198.[Abstract/Free Full Text]
Barzilai B, Marshall WG Jr, Saffitz Je, et al: Avoidance
of embolic complications by ultrasonic characterization of the ascending
aorta. Circulation 1989; 80:1275.
Weinstein GS: Left hemispheric strokes in coronary
surgery: implication for end-hole aortic cannulas. Ann Thorac Surg
2001; 71:128.[Abstract/Free Full Text]
Macoviak JA, Hwang J, Boerjan KL, Deal DD: Comparing
dual-stream and standard cardiopulmonary bypass in pigs. Ann Thorac
Surg 2002; 73:203.[Abstract/Free Full Text]
Harringer W: Capture of a particulate embolic during
cardiac procedures in which aortic cross-clamp is used. Ann Thorac Surg
2000; 70:1119.[Abstract/Free Full Text]
Hammon JW, Stump DA, Kon ND, et al: Risk factors and
solutions for the development of neurobehavioral changes after coronary artery
bypass grafting. Ann Thorac Surg 1998; 63:1613.
Loop FD, Higgins TL, Panda R, et al: Myocardial
protection during cardiac operations: decreased morbidity and lower cost with
blood cardioplegia and coronary sinus perfusion. J Cardiovasc Surg
1992; 104:608.
Sundt TM, Barner HB, Camillo CJ, et al: Total arterial
revascularization with an internal thoracic artery and radial artery T graft.
Ann Thorac Surg 1999; 68:399.[Abstract/Free Full Text]
Tector AJ, Amundsen S, Schmahl TM, et al: Total
revascularization with T Grafts. Ann Thorac Surg 1994; 57:33.[Abstract]
Menninger FJ 3rd, Rosenkranz ER, Utley JR, et al:
Interstitial hydrostatic pressure in patients undergoing CABG and valve
replacement. J Thorac Cardiovasc Surg 1980; 79:181.[Abstract]
Downing SW, Savage EB, Streicher JS, et al: The stretched
ventricle: myocardial creep and contractile dysfunction after acute
nonischemic ventricular distention. J Thorac Cardiovasc Surg 1992;
104:996.[Abstract]
Shaw PJ: The incidence and nature of neurological
morbidity following cardiac surgery: a review. Perfusion 1989; 4:83.
Newman S: The incidence and nature of neuropsychological
morbidity following cardiac surgery. Perfusion 1989; 4:93.
Svensson LG, Nadolny EM, Kimmel WA: Multimodal protocol
influence on stroke and neurocognitive deficit prevention after ascending/arch
aortic operations. Ann Thorac Surg (in press).
Newman S, Smith P, Treasure T, et al: Acute
neuropsychological consequences of coronary artery bypass surgery. Curr
Psychol Res Rev 1987; 6:115.
Murkin JM, Stump DA, Blumenthal JA, et al: Defining
dysfunction: group means versus incidence analysis-a statement of consensus.
Ann Thorac Surg 1997; 64:904.[Medline]
Baird A, Benfield A, Schlaug G, et al: Enlargement of
human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic
resonance imaging. Ann Neurol 1997; 41:581.[Medline]
Bendszus M, Reents W, Franke D, et al: Brain damage after
coronary artery bypass grafting. Arch Neurol 2002; 59:1090.[Abstract/Free Full Text]
Rosen B, Belliveau J, Vevea J, et al: Perfusion imaging
with NMR contrast agents. Magn Reson Med 1990; 14:249.[Medline]
Maragos PJ, Schmechel DE: Neuro-specific enolase, a
clinically useful marker for neurons and neuroendocrine cells. Annu Rev
Neuro Sci 1987; 10:269.
Persson L, Hardemark HG, Gustafsson J, et al: S-100
protein and neuro-specific enolase in cerebrospinal fluid and serum: markers
of cell damage in human central nervous system. Stroke 1987; 18:911.[Abstract]
Zimmer DB, Cornwall EH, Landar A, Song W: The S-100
protein family: history, function, and expression. Brain Res Bull 1995;
37: 417.[Medline]
Johnsson P, Blomquist S, Luhrs C, et al: Neuron-specific
enolase increases in plasma during and immediately after extracorporeal
circulation. Ann Thorac Surg 2000; 69:750.[Abstract/Free Full Text]
Anderson RE, Hansson LO, Liska J, et al: The effect of
cardiotomy suction on the brain injury marker S100 b after cardiopulmonary
bypass. Ann Thorac Surg 2000; 69:847.[Abstract/Free Full Text]
Shaw PJ, Bates D, Cartlidge NE, et al: Neurologic and
neuropsychological morbidity following major surgery: comparison of coronary
artery bypass and peripheral vascular surgery. Stroke 1987; 18:700.[Abstract]
Moller JT, Cluitmans P, Rasmussen LS, et al: Long-term
postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD
investigators, International Study of Post-Operative Cognitive Dysfunction.
Lancet 1998; 351:857.[Medline]
Jones EL, Weintraub WS, Craver JM, et al: Coronary bypass
surgery: is the operation different today? J Thorac Cardiovasc Surg
1991; 101:108.[Abstract]
Tardiff BE, Newman MF, Saunders AM, et al: Preliminary
report of a genetic basis for cognitive decline after cardiac operations.
Ann Thorac Surg 1997; 64:715.[Abstract/Free Full Text]
Roach GW, Kanchugar M, Mangano CM, et al: Adverse
cerebral outcomes after coronary bypass surgery: multicenter study of
perioperative ischemia research groups and the ischemia research and education
foundation investigators. N Engl J Med 1996; 335:1857.[Abstract/Free Full Text]
Weintraub WS, Wenger NK, Jones EL, et al: Changing
clinical characteristics of coronary surgery patients: differences between men
and women. Circulation 1993; 88:79.
Goto T, Baba T, Yoshitake A, et al: Craniocervical and
aortic atherosclerosis as neurologic risk factors in coronary surgery. Ann
Thorac Surg 2000; 69:834.[Abstract/Free Full Text]
Wareing TH, Davila-Roman VG, Daily BB, et al: Strategy
for the reduction of stroke incidence in cardiac surgical patients. Ann
Thorac Surg 1993; 55:1400.[Abstract]
Stump DA, Brown WR, Moody DM, et al: Microemboli and
neurologic dysfunction after cardiovascular surgery. Semin Cardiothorac
Vasc Anesth 1999; 3:47.
Tuman KJ, McCarthy RJ, Najafi H, et al: Differential
effects of advanced age on neurologic and cardiac risks of coronary
operations. J Thorac Cardiovasc Surg 1992; 104:1510.[Abstract]
Jones TJ, Stump DA, Deal D, et al: Hypothermia protects
the brain from embolization by reducing and redirecting the embolic load.
Ann Thorac Surg 1999; 68:1465.[Free Full Text]
Gold JP, Charlson ME, Williams-Russo P: Improvement of
outcomes after coronary artery bypass; a randomized trial comparing high verus
low mean arterial pressure. J Thorac Cardiovasc Surg 1995; 110:1302.[Abstract/Free Full Text]
Murkin JM, Farrar JK, Tweed WA, et al: Cerebral
autoregulation and flow/metabolism coupling during cardiopulmonary bypass: the
role of PaCO2. Anesth Analg 1987; 66:665.
Hill AG, Groom RC, Tewksbury L, et al: Sources of gaseous
microemboli during cardiopulmonary bypass. Proc Am Acad Cardiovasc
Perfus 1988;
9:122.
Blauth CI: Macroemboli and microemboli during
cardiopulmonary bypass. Ann Thorac Surg 1995; 59:1300.[Abstract/Free Full Text]
Helps SC, Parsons DW, Reilly PL, et al: The effect of gas
emboli on rabbit cerebral blood flow. Stroke 1990; 21:94.[Abstract]
Moody DM, Brown WR, Challa VR, et al: Efforts to
characterize the nature and chronicle the occurrence of brain emboli during
cardiopulmonary bypass. Perfusion 1995; 9:316.
Cook DJ, Oliver WC, Orsulak TA, et al: Cardiopulmonary
bypass temperature, hematocrit, and cerebral oxygen delivery in humans. Ann
Thorac Surg 1995; 60:1671.[Abstract/Free Full Text]
Martin TC, Craver JM, Gott MP, et al: Prospective,
randomized trial of retrograde warm-blood cardioplegia: myocardial benefit and
neurological threat. Ann Thorac Surg 1994; 59:298.
Engelman RM, Pleet AB, Rouson JA, et al: What is the best
perfusion temperature for coronary revascularization? J Thorac Cardiovasc
Surg 1996; 112:1622.[Abstract/Free Full Text]
Avraamides EJ, Murkin JM: The effect of surgical
dislocation of the heart on cerebral blood flow in the presence of a single,
two-stage venous cannula during cardiopulmonary bypass. Can J Anaesth
1996; 43:A36.
Nathan HJ, Wells GA, Munson JL, Wozny D: Neuroprotective
effect of mild hypothermia in patients undergoing coronary artery surgery with
cardiopulmonary bypass. Circulation 2001; 104(suppl I): I-85.[Medline]
Jones T, Roy RC: Should patients be normothermic in the
immediate postoperative period? Ann Thorac Surg 1999; 68:1454.[Free Full Text]
Brown R, Wright G, Royston D: A comparison of two systems
for assessing cerebral venous oxyhaemoglobin saturation during cardiopulmonary
bypass in humans. Anaethesia 1993; 48:697.
Michenfelder JD: The interdependency of cerebral
functional and metabolic effects following massive doses of thiopental in the
dog. Anesthesiology 1974; 41:231.[Medline]
Nussmeier N, Arlund C, Slogoff S: Neuropsychiatric
complications after cardiopulmonary bypass: cerebral protection by a
barbiturate. Anesthesiology 1986; 64:165.[Medline]
Arrowsmith JE, Harrison MJG, Newman SP, et al:
Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial
of remacemide during coronary artery bypass in 171 patients. Stroke
1998; 29:2357.[Abstract/Free Full Text]
Mitchell SJ, Pellet O, Gorman DF: Cerebral protection by
lidocaine during cardiac operations. Ann Thorac Surg 1999; 67:1117.[Medline]
Diegeler A, Hirsch R. Schneider F, et al: Neuromonitoring
and neurocognitive outcome in off-pump versus conventional coronary bypass
operation. Ann Thorac Surg 2000; 69:1162.[Abstract/Free Full Text]
Dijk DV, Jansen EWL, Hijman R, et al: Cognitive outcome
after off-pump and on-pump coronary artery bypass graft surgery. JAMA
2002; 287:1405.[Abstract/Free Full Text]
Newman MF, Kirchner JL, Phillips-Bute B, et al:
Longitudinal assessment of neurocognitive function after coronary artery
bypass grafting. N Engl J Med 2001; 344:395.[Abstract/Free Full Text]
Sotaniemi KA: Cerebral outcome after extracorporeal
circulation: comparison between prospective and retrospective evaluations.
Arch Neurol 1983; 40:75.[Abstract]
Maggart M, Stewart S: The mechanisms and management of
non-cardiogenic pulmonary edema following cardiopulmonary bypass. Ann
Thorac Surg 1987; 43:231.[Abstract]
Lloyd J, Newman J, Brigham K: Permeability pulmonary
edema: diagnosis and management. Arch Intern Med 1984; 144:143.[Abstract]
Allardyce D, Yoshida S, Ashmore P: The importance of
microembolism in the pathogenesis of organ dysfunction caused by prolonged use
of the pump oxygenator. J Thorac Cardiovasc Surg 1966; 52:706.[Medline]
Tonz M, Mihaljevic T, von Segesser LK, et al: Acute lung
injury during cardiopulmonary bypas: are the neutrophils responsible?
Chest 1995; 108:1551.[Abstract]
Chenoweth DE, Cooper SW, Hugli TE, et al: Complement
activation during cardiopulmonary bypass: evidence for generation of C3a and
C5a anaphylatoxins. N Engl J Med 1981; 304:497.[Abstract]
Royston D, Fleming JS, Desai JB, et al: Increased
production of peroxidation products associated with cardiac operations. J
Thorac Cardiovasc Surg 1986; 91:759.[Abstract]
Craddock PR, Fehr J, Brigham KL, et al: Complement and
leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med
1977; 296:769.[Abstract]
Hammerschmidt DE, Stroncek DF, Bowers TK, et al:
Complement activation and neutropenia during cardiopulmonary bypass. J
Thorac Cardiovasc Surg 1981; 81:370.[Abstract]
McGowan FX, del Nido PJ, Kurland G, et al:
Cardiopulmonary bypass significantly impairs surfactant activity in children.
J Thorac Cardiovasc Surg 1993; 106:968.[Abstract]
Oster JB, Sladen RN, Berkowitz DE: Cardiopulmonary bypass
and the lung, in Gravlee GP, Davis RF, Kurusz M, Utley JR (eds):
Cardiopulmonary Bypass: Principles and Practice. Philadelphia,
Lippincott Williams & Wilkins, 2000; p 367.
Magnusson L, Zemgulis V, Tenling A, et al: Use of a vital
capacity maneuver to prevent atelectasis after cardiopulmonary bypass: an
experimental study. Anesthesiology 1998; 88:134.[Medline]
Cogliati AA, Menichetti A, Tritapepe L, et al: Effects of
three techniques of lung management on pulmonary function during
cardiopulmonary bypass. Acta Anaesth Belg 1996; 47:73.[Medline]
Sirivella A, Gielchinsky I, Parsonnet V: Management of
catheter-induced pulmonary artery perforation: a rare complication in
cardiovascular operations. Ann Thorac Surg 2001; 72:2056.[Abstract/Free Full Text]
Rinder CS, Fontes M, Mathew JP, et al: Neutrophil CD11b
upregulation during cardiopulmonary bypass is associated with postoperative
renal injury. Ann Thorac Surg (in press).
Chertow G, Mazarus J, Christiansen C, et al: Preoperative
renal risk stratification. Circulation 1997; 95:878.[Abstract/Free Full Text]
Zanardo G, et al: Acute renal failure in the patient
undergoing cardiac operation: prevalence, mortality rate, and main risk
factors. J Thorac Cardiovasc Surg 1994; 107:1489.[Abstract/Free Full Text]
Settergren G, Ohqvist G. Renal dysfunction during cardiac
surgery. Curr Opin Anesthesiol 1994; 7:59.
Feindt PR, Walcher S, Volkmer I, et al: Effects of
high-dose aprotinin on renal function in aortocoronary bypass grafting. Ann
Thorac Surg 1995; 60:1076.[Abstract/Free Full Text]
Utley JR: Renal function and fluid balance with
cardiopulmonary bypass, in Gravlee GP, Davis RF, Utley JR (eds):
Cardiopulmonary Bypass: Principles and Practice. Baltimore, Williams
& Wilkins, 1993; p 488.
Clyne DH, Kant KS, Pesce AJ, et al: Nephrotoxicity of low
molecular weight serum proteins: physicochemical interactions between
myoglobin, hemoglobin, Bence Jones proteins and Tamm-Horsfall mucoprotein.
Curr Prob Clin Biochem 1979; 9:299.
Abel, RM, Buckley, MJ, Austen, WG, et al: Etiology,
incidence and prognosis of renal failure following cardiac operations: results
of a prospective analysis of 500 consecutive patients. J Thorac Cardiovasc
Surg 1976; 71:32.
Conger J: Interventions in clinical acute renal failure:
what are the data? Am J Kidney Dis 1995; 26:565.[Medline]
Wiebe K, Meyer M, Wahlers T, et al: Acute renal failure
following cardiac surgery is reverted by administration of urodilatin (INN:
ularitide). Eur J Med Res 1996; 1:259.[Medline]
Blachey JD, Henrich WL: The diagnosis and management of
acute renal failure. Semin Nephrol 1981; 1:11.
Mangano C, et al: Renal dysfunction after myocardial
revascularization: risk factors, adverse outcomes and hospital resource
utilization. The Multicenter Study of Perioperative Ischemia Research Group.
Anesth Analg 1998; 1:3.
Welbourn N, Melrose DG, Moss DW: Changes in serum enzyme
levels accompanying cardiac surgery with extracorporeal circulation. J Clin
Pathol 1966; 19:220.[Medline]
Collins JD, Ferner R, Murray A, et al: Incidence and
prognostic importance of jaundice after cardiopulmonary bypass surgery.
Lancet 1983; 1:1119.[Medline]
Ryan TA, Rady MY, Bashour CA, et al: Predictors of
outcome in cardiac surgical patients with prolonged intensive care stay.
Chest 1997; 112:1035.[Abstract]
Krasna MJ, Flancbaum L, Trooskin SZ, et al:
Gastrointestinal complications after cardiac surgery. Surgery 1988;
104:773.[Medline]
Rattner DW, Gu Z-Y, Vlahakes GJ, et al: Hyperamylasemia
after cardiac surgery. Ann Surg 1989; 209:279.[Medline]
Fernandez-del Castillo C, Harringer W, Warshaw AL, et al:
Risk factors for pancreatic celular injury after cardiopulmonary bypass. N
Engl J Med 1991; 325:382.[Abstract]
Haas GS, Warshaw AL, Daggett WM, et al: Acute
pancreatitis after cardiopulmonary bypass. Am J Surg 1985; 149:508.[Medline]
Feiner H: Pancreatitis after cardiac surgery: a
morphologic study. Am J Surg 1976; 131:684.[Medline]
Lefor AT, Vuocolo P, Parker FB Jr, et al: Pancreatic
complications following cardiopulmonary bypass: factors influencing mortality.
Arch Surg 1992; 127:1225.[Abstract]
Izsak EM, Shike M, Roulet M, et al: Pancreatitis in
association with hypercalcemia in patients receiving total parenteral
nutrition. Gastroenterology 1980; 79:555.[Medline]
Mithofer K, Fernandes-del Castillo C, Frick TW, et al:
Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen
activation in the rat. Gastroenterology 1995; 109:239.[Medline]
Waele BD, Smitz J, Willems G: Recurrent pancreatitis
secondary to hypercalcemia following vitamin D poisoning. Pancreas
1989; 4:378.[Medline]
Rose DM, Ranson JHC, Cunningham JN, et al: Patterns of
severe pancreatic injury following cardiopulmonary bypass. Ann Surg
1984; 199:168.[Medline]
Mori A, Watanabe K, Onoe M, et al: Regional blood flow in
the liver, pancreas and kidney during pulsatile and nonpulsatile perfusion
under profound hypothermia. Jpn Circ J 1988; 52:219.[Medline]
Decker GAG, Josselsohn E, Svensson L, et al: Acute
gastroduodenal complications after cardiopulmonary bypass surgery. S Afr J
Surg 1984; 22:261.[Medline]
Fiddian-Green RG, Baker S: Predictive valve of the
stomach wall pH for complications after cardiac operations: comparison with
other monitoring. Crit Care Med 1987; 15:153.[Medline]
Shangraw RE: Splanchnic, hepatic and visceral effects, in
Gravlee GP, Davis RF, Utley JR (eds): Cardiopulmonary Bypass: Principles
and Practice. Baltimore, Williams & Wilkins, 1993; p 391.
Heikkinen LO, Ala-Kulju KV: Abdominal complications
following cardiopulmonary bypass in open-heart surgery. Scand J Thorac
Cardiovasc Surg 1987; 21:1.[Medline]
Hanks JB, Curtis SE, Hanks BB, et al: Gastrointestinal
complications after cardiopulmonary bypass. Surgery 1982; 92:394.[Medline]
Moneta GL, Misbach GA, Ivey TD: Hypoperfusion as a
possible factor in the development of gastrointestinal complications after
cardiac surgery. Am J Surg 1985; 149:648.[Medline]